Pediatric Allergic Reaction General Pediatric Assessment NO (Mild) Evidence of anaphylaxis? YES (Moderate/Severe) EPINEPHRINE A Vascular Access E Assist patient with own auto-injector EPINEPHRINE 1:1000, 0.01 mg/kg IM; A max single dose 0.5 mg; may repeat q 5 min DIPHENHYDRAMINE up to max 1.5 mg 1 mg/kg IM/IV/IO/PO; A max 50 mg ALBUTEROL E Assist patient with MDI A 2.5 mg in 3 ml SVN; repeat as needed OR A LEVALBUTEROL 1.25 mg SVN; repeat as needed Ventilation Management Reassess patient q 5 min P Cardiac monitor Vascular access 20 ml/kg IV/IO NS or LR bolus; Allergic Reaction – mild immune response to an allergen with may repeat up to 60 ml/kg symptoms such as hives or local swelling/itching A DIPHENHYDRAMINE 1 mg/kg IM/IV/IO/PO; max 50 mg Anaphylaxis – moderate/severe reaction meeting either of these criteria: • Exposure to known or likely allergen with hypotension OR Pt in persistent shock? If Yes, then respiratory compromise • Two or more of the following after exposure to likely allergen: skin/mucosal changes (hives, flushing, edema); Consider respiratory compromise (SOB, wheezing, stridor, PUSH DOSE EPINEPHRINE hypoxia); hypotension or signs of shock; persistent GI P 0.1 mcg/kg IV/IO, max dose 5 mcg symptoms (abdominal pain, vomiting) Titrate to SBP>70 mm Hg + 2 X age Continue General Pediatric Assessment Pediatric Allergic Reaction (Revised and MAB approved 10/2/2024) 78